Filing Details
- Accession Number:
- 0001104659-22-067761
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-02 20:01:53
- Reporting Period:
- 2022-05-31
- Accepted Time:
- 2022-06-02 20:01:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1425205 | Iovance Biotherapeutics Inc. | IOVA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221449 | Michael Weiser | C/O Iovance Biotherapeutics, Inc. 825 Industrial Road, 4Th Floor San Carlos CA 94070 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-31 | 2,187 | $6.79 | 104,819 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-31 | 7,813 | $6.80 | 112,632 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 28,484 | Indirect | By Actin Capital Partners, LLC |
Footnotes
- The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
